The 2010 Doctors' Choice Awards will be held Thursday, September 16th at Comix in New York City from 3:30 - 6:30 PM ET. Vince Parry, President, Y Brand NOTE: Online registration closes Monday, September 9th.
THE DOCTORS' CHOICE AWARDS
Master of Ceremonies:
Chief Branding Officer, inVentiv Communications
(More about Vince Parry...)
On-site registration will be available.
Please select one of the three registration categories:
|
Individual Pricing: |
Group of Five: |
Group of Ten: Member: $1500 Non-Member:$1750 (Click here to register as a group of ten and receive discounted pricing) |
2010 DOCTORS' CHOICE WINNERS! Final Program Advertising Details For questions please contact BreAnne Clark, Meeting Coordinator: Vince Parry is responsible for developing and leading inVentiv Communications’ branding and brand planning capabilities. He is the founder and leader of Y Brand, inVentiv’s branding group. Vince has conducted branding initiatives for clients such as: J&J, Merck, Allergan, Biogen Idec, Genentech, Bayer, Lilly, Roche and TAP, among many others since he joined the company in 2001. He recently was named one of the top 100 most inspiring people in the life sciences industry by PharmaVoice. ________________ The Doctors' Choice Awards program was established by AMM in 2003 to determine the effectiveness of journal ads for pharmaceutical products. Every year physicians are polled by Readex Research, an independent firm, to determine which ads prompted their positive response. Invitations in AMM member medical publications and an email campaign direct physicians to a designated Web site to view the ads. Read more about the Doctors' Choice Awards... View text of keynote address by Jay Carter Senior Vice President, Director of Client Services, AbelsonTaylor
856-380-6814 or bclark@ammonline.org
About Vince Parry, Master of Ceremonies for the 2010 Doctors' Choice Awards:
Vince previously served at Young and Rubicam as Executive Vice President/Chief Creative Officer of Sudler & Hennessey for 13 years.
Parry has appeared on NBC Nightly News with Brian Williams and BBC radio, and is a frequent contributor to Medical Marketing and Media, PharmaVoice, Pharmaceutical Executive, and MedAdNews. He has an MA from Indiana University.
Doctors' Choice 2008:
Press Release: Jay Carter Tells Pharmaceutical Marketers They Play "Privileged" Role in Healthcare - View PDFPress Release:
Pfizer's Chantix Wins The Doctors' Choice Award
As Highest Scoring General Practice Advertisement
The 2008 Winners
Photo Album
2007 Winners 2007 Ads/Results Analysis (Study by Charles Hunt)
More about Doctors' Choice
No other creative awards program in the pharmaceutical field goes to the prescribing audience to measure the effectiveness of products' promotional messages since they rely upon juried awards decided by advertising professionals. The Doctors' Choice Awards are unique in the number of ads evaluated, the size of the audience approached, and the response level obtained. In fact, the awards are seen as breaking new ground in audience feedback research on advertisements.
The number of physicians taking part in the research is indicative of the key place journal advertising plays in the pharmaceutical promotional mix. Additionally, the company/advertising agency product teams on ads qualifying in the top places in disease and unit size categories can have confidence that their copy and graphics are a success with physicians. Physician response to The Doctors’ Choice research confirms the effectiveness of journal advertising and winning ads can be recognized as successful based on positive reactions by MDs to their sales messages and an increase in marketshare.
